Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 3.1B | 3.0B | 2.8B | 2.6B |
Cost of revenue | 651M | 631M | 584M | 552M |
Gross profit | 2.4B | 2.3B | 2.2B | 2.1B |
Operating expense | ||||
Research & development | 703M | 668M | 626M | 643M |
Selling general and admin | 1.3B | 1.3B | 1.2B | 1.2B |
Other operating expenses | — | — | — | — |
Operating income | 451M | 374M | 418M | 240M |
Non operating interest income | ||||
Income | 115M | 106M | 108M | 104M |
Expense | 6M | 5M | 6M | 6M |
Other income expense | -5M | -12M | -4M | -4M |
Pretax income | 555M | 463M | 516M | 334M |
Tax provision | 95M | 79M | 84M | 72M |
Net income | 460M | 384M | 432M | 262M |
Basic EPS | 2.2 | 1.9 | 2.1 | 1.3 |
Diluted EPS | 2.2 | 1.8 | 2.1 | 1.3 |
Basic average shares | 206.8M | 206M | 206M | 206M |
Diluted average shares | 209.4M | 209M | 209M | 208M |
EBITDA | 721M | 622M | 666M | 476M |
Net income from continuing op. | 460M | 384M | 432M | 262M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |